Ozden Rabia Gurses
- SEC CIK
- 0001814883
No open-market purchases or sales filed in the past year.
Current role at each company
- ADVM Adverum Biotechnologies, Inc.Chief Medical Officeras of Dec 10, 2025
- OCUL Ocular Therapeutix, IncChief Medical Officeras of Feb 6, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ozden Rabia Gurses as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OCUL Ocular Therapeutix, Inc
Chief Medical Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 (view filing) | Feb 5 | 1 day | Ozden Rabia GursesChief Medical Officer | SSale | +6.35K | $4.86 | +$30.8K | +4.3%153.1K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Ozden Rabia GursesChief Medical Officer | SSale | −7.76K | $4.95 | −$38.4K | −7.7%92.8K after | |
| Jul 11, 2023 (view filing) | Jul 7 | 4 days | Ozden Rabia GursesChief Medical Officer | SSale | −832 | $4.93 | −$4.10K | −0.8%100.5K after | |
| Feb 8, 2023 (view filing) | Feb 6 | 2 days | Ozden Rabia GursesChief Medical Officer | SSale | −6.42K | $4.24 | −$27.2K | −6.0%101.4K after |